TR-1: Standard form for notification of major holdings

Cambridge, UK - 27th February 2018

Nuformix, the pharmaceutical development company using cocrystal technology to unlock the therapeutic potential of approved small molecule drugs, announces : TR-1: Standard form for notification of major holdings

Download News

Back to all News